These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12556915)

  • 1. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine.
    Potkin SG; Basile VS; Jin Y; Masellis M; Badri F; Keator D; Wu JC; Alva G; Carreon DT; Bunney WE; Fallon JH; Kennedy JL
    Mol Psychiatry; 2003 Jan; 8(1):109-13. PubMed ID: 12556915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs.
    Ota VK; Spíndola LN; Gadelha A; dos Santos Filho AF; Santoro ML; Christofolini DM; Bellucco FT; Ribeiro-dos-Santos ÂK; Santos S; Mari Jde J; Melaragno MI; Bressan RA; Smith Mde A; Belangero SI
    Schizophr Res; 2012 Dec; 142(1-3):206-8. PubMed ID: 23036699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia: evidence of a sex effect.
    Cohen RM; Nordahl TE; Semple WE; Pickar D
    Neuropsychopharmacology; 1999 Nov; 21(5):632-40. PubMed ID: 10516959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in PET scan imaging of neuroreceptors in schizophrenia.
    Sedvall G; Pauli S; Farde L; Karlsson P; Nyberg S; Nordström AL
    Isr J Psychiatry Relat Sci; 1995; 32(1):22-9. PubMed ID: 7622344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia.
    Molina V; Reig S; Sarramea F; Sanz J; Francisco Artaloytia J; Luque R; Aragüés M; Pascau J; Benito C; Palomo T; Desco M
    Psychiatry Res; 2003 Nov; 124(3):153-61. PubMed ID: 14623067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.
    de Matos LP; Santana CV; Souza RP
    Psychiatry Res; 2015 Sep; 229(1-2):586-8. PubMed ID: 26213377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex.
    Lahti AC; Holcomb HH; Weiler MA; Medoff DR; Frey KN; Hardin M; Tamminga CA
    Neuropsychopharmacology; 2004 Jan; 29(1):171-8. PubMed ID: 14520337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.
    Hwang R; Shinkai T; De Luca V; Ni X; Potkin SG; Lieberman JA; Meltzer HY; Kennedy JL
    J Psychopharmacol; 2007 Sep; 21(7):718-27. PubMed ID: 17092969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study.
    Conley RR; Kelly DL; Beason-Held LL; Holcomb HH; Richardson CM
    J Psychopharmacol; 2004 Sep; 18(3):429-31. PubMed ID: 15358989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin.
    Fernández E; Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
    Schizophr Res; 2010 Aug; 121(1-3):213-7. PubMed ID: 20591628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene.
    Rietschel M; Naber D; Oberländer H; Holzbach R; Fimmers R; Eggermann K; Möller HJ; Propping P; Nöthen MM
    Neuropsychopharmacology; 1996 Nov; 15(5):491-6. PubMed ID: 8914122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
    Talvik M; Nordström AL; Nyberg S; Olsson H; Halldin C; Farde L
    Am J Psychiatry; 2001 Jun; 158(6):926-30. PubMed ID: 11384901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
    Karlsson P; Farde L; Halldin C; Sedvall G
    Am J Psychiatry; 2002 May; 159(5):761-7. PubMed ID: 11986129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients.
    Nordström AL; Farde L; Nyberg S; Karlsson P; Halldin C; Sedvall G
    Am J Psychiatry; 1995 Oct; 152(10):1444-9. PubMed ID: 7573582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.
    Bartlett EJ; Brodie JD; Simkowitz P; Schlösser R; Dewey SL; Lindenmayer JP; Rusinek H; Wolkin A; Cancro R; Schiffer W
    Am J Psychiatry; 1998 Mar; 155(3):337-43. PubMed ID: 9501742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine.
    Malhotra AK; Goldman D; Ozaki N; Breier A; Buchanan R; Pickar D
    Am J Psychiatry; 1996 Aug; 153(8):1092-4. PubMed ID: 8678181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone.
    Still DJ; Dorson PG; Crismon ML; Pousson C
    Psychiatr Serv; 1996 Dec; 47(12):1382-4. PubMed ID: 9117479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia.
    Buchsbaum MS; Potkin SG; Marshall JF; Lottenberg S; Teng C; Heh CW; Tafalla R; Reynolds C; Abel L; Plon L
    Neuropsychopharmacology; 1992 May; 6(3):155-63. PubMed ID: 1599606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.